Mpox (monkeypox)

Mpox (monkeypox) is a thematic concept centered on prevention, detection, and treatment of orthopoxvirus infections. Core tracks span vaccines and antivirals, PCR/rapid diagnostics, epidemiological surveillance and digital tracing, infection-control/PPE, and public-health logistics.The sector's total market cap is 368.17 billion USD, with a 24h change of +1.22%. Among 5 constituents, 4 are up (80.00%) and 1 are down (20.00%). The top gainer is GeoVax Labs, Inc. New (GOVX), with a 24h increase of +3.05%.Modest rebound with weak breadth and narrow leadership. Near term, follow liquid leaders; longer term, prioritize clinical/regulatory milestones, balance-sheet strength, and rate sensitivity.